About Akums Drugs and Pharmaceuticals
Akums Drugs and Pharmaceuticals operates in the 441,826.00 segment. The shares listed at ₹725.00, a 6.77% move from the issue price. Akums Drugs and Pharmaceuticals is a Mainboard IPO with an issue size of ₹1,856.74 crore, proposed for listing on BSE, NSE. The offer opens on 30th Jul 2024 and closes on 1st Aug 2024. The issue structure includes a fresh issue of ₹680.99 crore and an offer-for-sale component of ₹1,175.75 crore. The current listing schedule points to 6th Aug 2024.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/